Inhibition of matrix metalloproteinase-3 and-13 synthesis induced by IL-1β in chondrocytes from mice lacking microsomal prostaglandin E synthase-1

Journal of Immunology

Volumn 185, Issue 10, 2010, Pages 6244-6252

  Gosset, Marjolaine ^a   Pigenet, Audrey ^a   Salvat, Colette ^a   Berenbaum, Francis ^a   Jacques, Claire ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; FORSKOLIN; INTERLEUKIN 1BETA; PROSTAGLANDIN E SYNTHASE 1; STROMELYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOGENICITY; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CHONDROCYTES; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; INTERLEUKIN-1BETA; INTRAMOLECULAR OXIDOREDUCTASES; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MICE; MICROSOMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78650633681     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903315     Document Type: Article

References (70)

1. Aigner, T., A. Sachse, P. M. Gebhard, and H. I. Roach. 2006. Osteoarthritis: pathobiology-targets and ways for therapeutic intervention. Adv. Drug Deliv. Rev. 58:128-149.
2. Laufer, S. 2003. Role of eicosanoids in structural degradation in osteoarthritis. Curr. Opin. Rheumatol. 15:623-627.
3. Bertazzolo, N., L. Punzi, M. P. Stefani, G. Cesaro, M. Pianon, B. Finco, and S. Todesco. 1994. Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions 41:90-92.
4. Attur, M. G., I. R. Patel, R. N. Patel, S. B. Abramson, and A. R. Amin. 1998. Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc. Assoc. Am. Physicians 110:65-72.
5. Amin, A. R., M. Attur, R. N. Patel, G. D. Thakker, P. J. Marshall, J. Rediske, S. A. Stuchin, I. R. Patel, and S. B. Abramson. 1997. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J. Clin. Invest. 99:1231-1237.
6. Amin, A. R., M. Dave, M. Attur, and S. B. Abramson. 2000. COX-2, NO, and cartilage damage and repair. Curr. Rheumatol. Rep. 2:447-453.
7. Hishinuma, T., H. Nakamura, T. Sawai, M. Uzuki, Y. Itabash, and M. Mizugaki. 1999. Microdetermination of prostaglandin E2 in joint fluid in rheumatoid arthritis patients using gas chromatography/selected ion monitoring. Prostaglandins Other Lipid Mediat. 58:179-186.
8. Park, J. Y., M. H. Pillinger, and S. B. Abramson. 2006. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 119:229-240.
9. Kojima, F., H. Naraba, S. Miyamoto, M. Beppu, H. Aoki, and S. Kawai. 2004. Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. Arthritis Res. Ther. 6: R355-R365.
10. Masuko-Hongo, K., F. Berenbaum, L. Humbert, C. Salvat, M. B. Goldring, and S. Thirion. 2004. Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. Arthritis Rheum. 50:2829-2838.
11. Li, X., H. Afif, S. Cheng, J. Martel-Pelletier, J. P. Pelletier, P. Ranger, and H. Fahmi. 2005. Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes. J. Rheumatol. 32:887-895.
12. Westman, M., M. Korotkova, E. af Klint, A. Stark, L. P. Audoly, L. Klareskog, A. K. Ulfgren, and P. J. Jakobsson. 2004. Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium. Arthritis Rheum. 50:1774-1780.
13. Kojima, F., H. Naraba, Y. Sasaki, R. Okamoto, T. Koshino, and S. Kawai. 2002. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells. J. Rheumatol. 29:1836-1842.
14. Stichtenoth, D. O., S. Thorén, H. Bian, M. Peters-Golden, P. J. Jakobsson, and L. J. Crofford. 2001. Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J. Immunol. 167:469-474.
15. Kamei, D., K. Yamakawa, Y. Takegoshi, M. Mikami-Nakanishi, Y. Nakatani, S. Oh-Ishi, H. Yasui, Y. Azuma, N. Hirasawa, K. Ohuchi, et al. 2004. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J. Biol. Chem. 279:33684-33695.
16. Kapoor, M., F. Kojima, M. Qian, L. Yang, and L. J. Crofford. 2007. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway. J. Biol. Chem. 282:5356-5366.
17. Trebino, C. E., J. D. Eskra, T. S. Wachtmann, J. R. Perez, T. J. Carty, and L. P. Audoly. 2005. Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. J. Biol. Chem. 280:16579-16585.
18. Trebino, C. E., J. L. Stock, C. P. Gibbons, B. M. Naiman, T. S. Wachtmann, J. P. Umland, K. Pandher, J. M. Lapointe, S. Saha, M. L. Roach, et al. 2003. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. USA 100:9044-9049.
19. Burrage, P. S., K. S. Mix, and C. E. Brinckerhoff. 2006. Matrix metalloproteinases: role in arthritis. Front. Biosci. 11:529-543.
20. Smith, G. N., Jr. 2006. The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis. Front. Biosci. 11:3081-3095.
21. Cawston, T. E. 1996. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol. Ther. 70:163-182.
22. Brew, K., D. Dinakarpandian, and H. Nagase. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477:267-283.
23. Fernandes, J. C., J. Martel-Pelletier, and J. P. Pelletier. 2002. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39:237-246.
24. Rannou, F., M. François, M. T. Corvol, and F. Berenbaum. 2006. Cartilage breakdown in rheumatoid arthritis. Joint Bone Spine 73:29-36.
25. Yamada, H., T. Kikuchi, O. Nemoto, K. Obata, H. Sato, M. Seiki, and M. Shinmei. 1996. Effects of indomethacin on the production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by human articular chondrocytes. J. Rheumatol. 23:1739-1743.
26. Tsutsumi, R., H. Ito, T. Hiramitsu, K. Nishitani, M. Akiyoshi, T. Kitaori, T. Yasuda, and T. Nakamura. 2008. Celecoxib inhibits production of MMP and NO via down-regulation of NF-kappaB and JNK in a PGE2 independent manner in human articular chondrocytes. Rheumatol. Int. 28:727-736.
27. Choi, Y. A., D. J. Lee, H. K. Lim, J. H. Jeong, J. K. Sonn, S. S. Kang, and S. H. Baek. 2004. Interleukin-1beta stimulates matrix metalloproteinase-2 expression via a prostaglandin E2-dependent mechanism in human chondrocytes. Exp. Mol. Med. 36:226-232.
28. Tung, J. T., C. E. Arnold, L. H. Alexander, V. Yuzbasiyan-Gurkan, P. J. Venta, D. W. Richardson, and J. P. Caron. 2002. Evaluation of the influence of prostaglandin E2 on recombinant equine interleukin-1beta-stimulated matrix metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures. Am. J. Vet. Res. 63:987-993.
29. Attur, M., H. E. Al-Mussawir, J. Patel, A. Kitay, M. Dave, G. Palmer, M. H. Pillinger, and S. B. Abramson. 2008. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J. Immunol. 181:5082-5088.
30. Tchetina, E. V., J. A. di Battista, D. J. Zukor, J. Antoniou, and A. R. Poole. 2007. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy. Arthritis Res. Ther. 9: R75.
31. Kunisch, E., A. Jansen, F. Kojima, I. Löffler, M. Kapoor, S. Kawai, I. Rubio, L. J. Crofford, and R. W. Kinne. 2009. Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-alpha on synovial fibroblasts via specific E prostanoid receptors/cAMP. J. Immunol. 183:1328-1336.
32. Truett, G. E., P. Heeger, R. L. Mynatt, A. A. Truett, J. A. Walker, and M. L. Warman. 2000. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29:52-54.
33. Gosset, M., F. Berenbaum, S. Thirion, and C. Jacques. 2008. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc. 3:1253-1260.
34. Salvat, C., A. Pigenet, L. Humbert, F. Berenbaum, and S. Thirion. 2005. Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage. Osteoarthritis Cartilage 13:243-249.
35. Bluteau, G., T. Conrozier, P. Mathieu, E. Vignon, D. Herbage, and F. Mallein-Gerin. 2001. Matrix metalloproteinase-1,-3,-13 and aggrecanase-1 and-2 are differentially expressed in experimental osteoarthritis. Biochim. Biophys. Acta 1526:147-158.
36. Mitchell, P. G., H. A. Magna, L. M. Reeves, L. L. Lopresti-Morrow, S. A. Yocum, P. J. Rosner, K. F. Geoghegan, and J. E. Hambor. 1996. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97:761-768.
37. Okada, Y., M. Shinmei, O. Tanaka, K. Naka, A. Kimura, I. Nakanishi, M. T. Bayliss, K. Iwata, and H. Nagase. 1992. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab. Invest. 66:680-690.
38. Wernicke, D., C. Seyfert, E. Gromnica-Ihle, and P. Stiehl. 2006. The expression of collagenase 3 (MMP-13) mRNA in the synovial tissue is associated with histopathologic type II synovitis in rheumatoid arthritis. Autoimmunity 39:307-313.
39. Yoshihara, Y., H. Nakamura, K. Obata, H. Yamada, T. Hayakawa, K. Fujikawa, and Y. Okada. 2000. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59:455-461.
40. Clements, D. N., S. D. Carter, J. F. Innes, W. E. Ollier, and P. J. Day. 2006. Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative polymerase chain reaction. Arthritis Res. Ther. 8: R158.
41. Flannelly, J., M. G. Chambers, J. Dudhia, R. M. Hembry, G. Murphy, R. M. Mason, and M. T. Bayliss. 2002. Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthritis Cartilage 10:722-733.
42. Su, S., J. Grover, P. J. Roughley, J. A. DiBattista, J. Martel-Pelletier, J. P. Pelletier, and M. Zafarullah. 1999. Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol. Int. 18:183-191.
43. Jeong, J. G., J. M. Kim, H. Cho, W. Hahn, S. S. Yu, and S. Kim. 2004. Effects of IL-1beta on gene expression in human rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 324:3-7.
44. -/-) mice. Arthritis Rheum. 56:905-909.
45. Yamakawa, K., S. Kamekura, N. Kawamura, M. Saegusa, D. Kamei, M. Murakami, I. Kudo, S. Uematsu, S. Akira, U. I. Chung, et al. 2008. Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders. Arthritis Rheum. 58:172-183.
46. Yan, C., and D. D. Boyd. 2007. Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. 211:19-26.
47. Jiménez, M. J., M. Balbín, J. M. López, J. Alvarez, T. Komori, and C. López-Otín. 1999. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol. Cell. Biol. 19:4431-4442.
48. Porte, D., J. Tuckermann, M. Becker, B. Baumann, S. Teurich, T. Higgins, M. J. Owen, M. Schorpp-Kistner, and P. Angel. 1999. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18:667-678.
49. Mengshol, J. A., M. P. Vincenti, and C. E. Brinckerhoff. 2001. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res. 29:4361-4372.
50. Selvamurugan, N., S. C. Jefcoat, S. Kwok, R. Kowalewski, J. A. Tamasi, and N. C. Partridge. 2006. Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo. J. Cell. Biochem. 99:545-557.
51. Lu, T., Y. Achari, P. Sciore, and D. A. Hart. 2006. Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site. Biochim. Biophys. Acta 1762:719-731.
52. Samuel, S., J. C. Twizere, K. K. Beifuss, and L. R. Bernstein. 2008. Nucleolin binds specifically to an AP-1 DNA sequence and represses AP1-dependent transactivation of the matrix metalloproteinase-13 gene. Mol. Carcinog. 47:34-46.
53. Sanchez, C., M. M. Mateus, M. P. Defresne, J. M. Crielaard, J. Y. Reginster, and Y. E. Henrotin. 2002. Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal antiinflammatory drugs. J. Rheumatol. 29:772-782.
54. Narumiya, S., Y. Sugimoto, and F. Ushikubi. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1193-1226.
55. Sato, T., K. Konomi, S. Yamasaki, S. Aratani, K. Tsuchimochi, M. Yokouchi, K. Masuko-Hongo, N. Yagishita, H. Nakamura, S. Komiya, et al. 2006. Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage. Arthritis Rheum. 54:808-817.
56. Otsuka, S., T. Aoyama, M. Furu, K. Ito, Y. Jin, A. Nasu, K. Fukiage, Y. Kohno, T. Maruyama, T. Kanaji, et al. 2009. PGE2 signal via EP2 receptors evoked by a selective agonist enhances regeneration of injured articular cartilage. Osteoarthritis Cartilage 17:529-538.
57. McCoy, J. M., J. R. Wicks, and L. P. Audoly. 2002. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J. Clin. Invest. 110:651-658.
58. Nishitani, K., H. Ito, T. Hiramitsu, R. Tsutsumi, S. Tanida, T. Kitaori, H. Yoshitomi, M. Kobayashi, and T. Nakamura. 2010. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes. J. Cell. Biochem. 109:425-433.
59. Masuko, K., M. Murata, K. Yudoh, H. Shimizu, M. Beppu, H. Nakamura, and T. Kato. 2010. Prostaglandin E2 regulates the expression of connective tissue growth factor (CTGF/CCN2) in human osteoarthritic chondrocytes via the EP4 receptor. BMC Res. Notes 3:5.
60. Kobayashi, T., K. Notoya, T. Naito, S. Unno, A. Nakamura, J. Martel-Pelletier, and J. P. Pelletier. 2005. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs. Arthritis Rheum. 52:479-487.
61. Fahmi, H., J. A. di Battista, J. P. Pelletier, F. Mineau, P. Ranger, and J. Martel-Pelletier. 2001. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum. 44:595-607.
62. Sabatini, M., A. Bardiot, C. Lesur, N. Moulharat, M. Thomas, I. Richard, and A. Fradin. 2002. Effects of agonists of peroxisome proliferator-activated receptor gamma on proteoglycan degradation and matrix metalloproteinase production in rat cartilage in vitro. Osteoarthritis Cartilage 10:673-679.
63. Bombardier, C., L. Laine, A. Reicin, D. Shapiro, R. Burgos-Vargas, B. Davis, R. Day, M. B. Ferraz, C. J. Hawkey, M. C. Hochberg, et al; VIGOR Study Group. 2000. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N. Engl. J. Med. 343:1520-1528, 2 p following 1528.
64. Silverstein, F. E., G. Faich, J. L. Goldstein, L. S. Simon, T. Pincus, A. Whelton, R. Makuch, G. Eisen, N. M. Agrawal, W. F. Stenson, et al. 2000. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284:1247-1255.
65. Bresalier, R. S., R. S. Sandler, H. Quan, J. A. Bolognese, B. Oxenius, K. Horgan, C. Lines, R. Riddell, D. Morton, A. Lanas, et al; Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. 2005. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med. 352:1092-1102.
66. Solomon, S. D., J. J. McMurray, M. A. Pfeffer, J. Wittes, R. Fowler, P. Finn, W. F. Anderson, A. Zauber, E. Hawk, M. Bertagnolli; Adenoma Prevention with Celecoxib (APC) Study Investigators. 2005. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med. 352:1071-1080.
67. Côté, B., L. Boulet, C. Brideau, D. Claveau, D. Ethier, R. Frenette, M. Gagnon, A. Giroux, J. Guay, S. Guiral, et al. 2007. Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors. Bioorg. Med. Chem. Lett. 17:6816-6820.
68. Xu, D., S. E. Rowland, P. Clark, A. Giroux, B. Côté, S. Guiral, M. Salem, Y. Ducharme, R. W. Friesen, N. Méthot, et al. 2008. MF63 [2-(6-chloro-1H-phenanthro[9, 10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation. J. Pharmacol. Exp. Ther. 326:754-763.
69. Jachak, S. M. 2007. PGE synthase inhibitors as an alternative to COX-2 inhibitors. Curr. Opin. Investig. Drugs 8:411-415.
70. Samuelsson, B., R. Morgenstern, and P. J. Jakobsson. 2007. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol. Rev. 59:207-224.